SaaS platform for R&D workflow automation, data integration, and regulatory compliance in life sciences
Instem operates a suite of SaaS products targeting preclinical research and regulatory workflows in life sciences. The tech stack reveals a mature enterprise architecture (Oracle, SQL Server, WildFire app servers, Azure infrastructure) with heavy testing infrastructure (Selenium, Cypress), suggesting complex deployment and integration challenges — consistent with their stated pain around software deployment complexity and data architecture scalability. Current hiring is engineering-led (12 engineers across 33 active roles) with geographic expansion underway across US, UK, India, Romania, China, and Japan.
Notable leadership hires: Product Director
Instem develops SaaS products for R&D teams in life science organizations, spanning study workflow automation, regulatory information management, computational toxicology, and preclinical data integration. The platform handles multi-tenant data architectures with emphasis on data governance, quality assurance, and regulatory compliance (SEND standards, regulatory submissions). Their portfolio includes the Autoscribe Matrix-Gemini product line. Customer base is concentrated in pharma, biotech, and CRO environments where regulatory precision and operational scale are critical.
Instem runs Oracle, SQL Server, WildFly/Tomcat application servers, and Azure cloud infrastructure. Testing is handled by Selenium and Cypress. C#, Java, Python, and Node.js cover application development.
Active hiring in United Kingdom, India, Romania, China, and Japan, in addition to the US headquarters. Mix spans engineering, sales, product, and operations roles globally.
Other companies in the same industry, closest in size